Factors Associated with Outcomes of Combined Phacoemulsification and Ahmed Glaucoma Valve Implantation

Korean Journal of Ophthalmology : KJO
Junki Kwon, Kyung Rim Sung

Abstract

To evaluate outcomes and factors associated with surgical failure in patients who underwent combined phacoemulsification and Ahmed glaucoma valve (AGV) implantation. This retrospective and longitudinal study enrolled 40 eyes (38 patients) that underwent combined phacoemulsification and AGV implantation. Visual acuity, intraocular pressure (IOP), and number of antiglaucoma medications were evaluated preoperatively and postoperatively. Complete success was defined as a last follow-up IOP of 6 to 21 mmHg without medication, qualified success as an IOP of 6 to 21 mmHg with medication, and failure as an IOP of >21 or <6 mmHg. The mean follow-up period was 18 ± 10 months. Preoperative diagnoses were chronic angle closure glaucoma (35.0%), neovascular glaucoma (22.5%), uveitic glaucoma (17.5%), primary open-angle glaucoma (15.0%), and other (10.0%). IOP decreased from a mean of 30.5 ± 8.7 to 14.5 ± 3.7 mmHg at the last follow-up visit (p < 0.001). Treatment was classified as qualified success in 18 eyes (45%), complete success in 15 (37.5%), and failure in seven (17.5%). Twenty-two eyes (55%) showed improvement in visual acuity. The most common postoperative complication was a transient hypertensive phase (five eyes, 12.5%). Tube-iris...Continue Reading

References

Mar 15, 1991·American Journal of Ophthalmology·S MelamedM Blumenthal
Sep 1, 1987·Ophthalmology·E J RockwoodW Feuer
Jul 1, 1995·American Journal of Ophthalmology·A L ColemanW C Panek
Jul 1, 1994·Ophthalmology·P S FellenbaumD K Heuer
Oct 1, 1996·Journal of Cataract and Refractive Surgery·K HayashiF Hayashi
May 22, 1998·Archives of Ophthalmology·Q H NguyenR K Parrish
Feb 5, 1999·American Journal of Ophthalmology·M C HuangR A Hill
Feb 5, 1999·American Journal of Ophthalmology·J A EnglertT A Cox
Feb 26, 2000·Ophthalmology·J K BurgoyneL B Cantor
Sep 12, 2003·American Journal of Ophthalmology·M Roy WilsonVera Haynatzka
Apr 7, 2005·BMC Ophthalmology·Sarah E BensonScott G Fraser
Nov 7, 2006·American Journal of Ophthalmology·Steven J GeddeDonald L Budenz
Mar 6, 2008·European Journal of Ophthalmology·N NassiriL Rahmani
May 15, 2010·Ophthalmology·Bharti R Nihalani, Deborah K VanderVeen
Aug 10, 2010·Ophthalmology·Gdih A GdihYvonne M Buys
Apr 2, 2011·Lancet·Harry A Quigley
Jun 13, 2012·Canadian Journal of Ophthalmology. Journal Canadien D'ophtalmologie·Colin Cook, Paul Foster
Jan 5, 2013·Current Opinion in Ophthalmology·Steven J GeddeRichard K Lee
Jul 4, 2013·Acta Ophthalmologica·Tetsuya YamamotoUNKNOWN Japan Glaucoma Society Survey of Bleb-related Infection
Jul 4, 2013·Journal of Refractive Surgery·Ana Paula CantoWilliam W Culbertson
Nov 20, 2013·Journal of Glaucoma·Jonathan H TzuSarah R Wellik
Mar 17, 2015·Journal of Glaucoma·Hun Jae Won, Kyung Rim Sung
Aug 8, 2015·Acta Ophthalmologica·Sanaa A Yassin

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Methods Mentioned

BETA
dissection

Software Mentioned

PASW Statistics

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.